Optimal donor selection for transplant to reduce GVHD risk and augment graft-versus-malignancy efficacy.
Saved in:
| Title: | Optimal donor selection for transplant to reduce GVHD risk and augment graft-versus-malignancy efficacy. |
|---|---|
| Authors: | Shaffer BC; Adult BMT Service, Memorial Sloan Kettering Cancer Center, New York, NY, United States; Department of Medicine, Weill Cornell Medical School, New York, NY, United States., Shaw BE; CIBMTR® (Center for International Blood and Marrow Transplant Research), Medical College of Wisconsin, Milwaukee, WI, United States; Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, United States. Electronic address: beshaw@mcw.edu. |
| Source: | Current opinion in immunology [Curr Opin Immunol] 2026 Jun; Vol. 100, pp. 102783. Date of Electronic Publication: 2026 Apr 29. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Elsevier Country of Publication: England NLM ID: 8900118 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0372 (Electronic) Linking ISSN: 09527915 NLM ISO Abbreviation: Curr Opin Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
